Navigation Links
FAME 2 Published in the New England Journal of Medicine, Volcano participates in the $84M NIH-Sponsored ISCHEMIA Trial
Date:8/28/2012

MUNICH and SAN DIEGO, Aug. 28, 2012 /PRNewswire/ -- Volcano Corporation (NASDAQ: VOLC) a worldwide leader in precision guided therapy tools, today celebrated the publication of the results of the FAME 2 trial in the New England Journal of Medicine (NEJM). Volcano also announced participation in the next major international functionally-guided study—ISCHEMIA that will include the newest PrimeWire® PRESTIGE PLUS Pressure Guidewires.

Ever since the COURAGE trial demonstrated that not every patient entering the cath lab benefits from stenting, the interventional cardiology community has been exploring more precise ways to identify which patients will benefit most from PCI, and which patients should instead be treated with optimal medical therapy (OMT) alone. The initial FAME study published in the NEJM showed that PCI outcomes can be improved by guiding a stent strategy using Fractional Flow Reserve (FFR) instead of angiography alone as was practiced in COURAGE. The results of the FAME study showed that the number of vessels that actually needed treatment was dramatically less than previously thought, and therefore reduced the complexity of the initial angiographic diagnosis.

FAME 2 (Fractional Flow Reserve-Guided PCI vs. Medical Therapy in Stable Coronary Disease) is the second FFR-guided randomized clinical trial to be published in the NEJM. It demonstrates that using stents to treat patients with proven ischemia by FFR does in fact deliver better outcomes than OMT alone in the combined endpoint of death, myocardial infarction (MI) and urgent revascularization. It is important to note that the FAME 2 trial was halted early by the Independent Data Safety Monitoring Board because it determined it was unethical to continue enrolling patients in the medical therapy only arm due to the increased risk of these significant adverse events.

"The FAME 2 study
'/>"/>

SOURCE Volcano Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Results For Phase 2b Trial Of Unique Investigational Cell-Based Therapy In Venous Leg Ulcers Published In The Lancet
2. MedVantx MedStart™ Solves Problem Highlighted in Study Published in Journal of the American Board of Family Medicine - Expired Medications in Physician Office Sample Closets
3. Study Results of Novocures NovoTTF™ Pivotal Phase 3 Trial Published in European Journal of Cancer
4. New Data from Silences Atu027 Anticancer Trial Published at ASCO
5. New Published Guidelines to Help Physicians Diagnose and Treat Lupus Kidney Disease
6. 1st SynCardia Total Artificial Heart Implant Performed in New England
7. New Study in The Journal of Maternal-Fetal and Neonatal Medicine Shows Fetal Cell-Free DNA in Maternal Blood Unaffected by Trisomy Risk
8. American Journal of Obstetrics and Gynecology Publishes PeriGen Research on Shoulder Dystocia
9. Elsevier Launches New Journal: Discourse, Context and Media
10. Elsevier Launches New Open Access Journal: Applied and Translational Genomics
11. Medical Device Daily Wins Prestigious SIPA Award for Outstanding Business Journalism
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... , Aug. 28, 2015  Delays in ... projects can slow down the decision-making process, resulting ... therefore, absolutely critical for biopharmaceutical companies to develop ... approval process for quicker and more meaningful insights. ... Best Practices, LLC, nearly three-quarters of benchmarked study ...
(Date:8/28/2015)... PUNE, India , August 28, 2015 ... "Cancer Biomarker Market by Tumor (Breast, Lung, Prostate) Type ... Immunoassay) Application (Diagnostic, Drug Discovery, Prognostic) & Geography - ... Biomarkers Market is expected to reach around 17,689.0 Million ... the forecast period of 2015 to 2020. ...
(Date:8/28/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/686gwf/investigation ... Report on China,s Bevacizumab Market ,2010-2019" report to ... trade name of Avastin, bevacizumab injection is the first ... was approved by CFDA to treat metastatic colorectal cancer. ... all come from Roche and its subsidiary Genectech. ...
Breaking Medicine Technology:Expediting the Pharmaceutical Market Research Process for Faster Insights 2Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 2Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 3Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 4Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 5Investigation Report on China's Bevacizumab Market 2015-2019 2
... 5, 2011 Today, Molecular Devices, a leading ... discovery and life sciences research, announced that the ... Devices. (Logo:   http://photos.prnewswire.com/prnh/20100406/SF82092LOGO ) ... continues to grow as a leading technology supply ...
... July 5, 2011 Regulators are brandishing a ... officers they suspect of wrongdoing—in effect, using an ... It is unclear whether they intend to routinely ... "death penalty" by some—but at a recent conference ...
Cached Medicine Technology:Genetix Joins Molecular Devices: Combining Businesses to be in a Better Position to Serve Customers 2Feds Might 'Banish' More Execs for Misconduct, Attorney Says 2Feds Might 'Banish' More Execs for Misconduct, Attorney Says 3
(Date:8/31/2015)... ... August 31, 2015 , ... The ... the use of health IT to create efficiencies in healthcare information exchange, announces ... . Taking place at the Hyatt Regency Reston in Reston, Va. from October ...
(Date:8/31/2015)... ... August 31, 2015 , ... Juvent Sports ( http://www.juvent.com ... of major sports figures who are finding joint pain relief after using their revolutionary ... men’s tennis player in the world said, “For the first time in over 20 ...
(Date:8/31/2015)... Atlanta, Georgia (PRWEB) , ... August 31, 2015 ... ... with the Eco Commerce Exchange and Organization Supporting Business Owners and provided a ... located in Atlanta, Georgia, represents the success possible to international companies expanding business ...
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... ... efficacy endpoint data collection, cloud analytics and workflow solutions will demonstrate multiple prototypes ... in Lisbon, Portugal, September 22-24, 2015. This is the only European event dedicated ...
(Date:8/31/2015)... ... August 31, 2015 , ... Global Digital Community, ... Hub in North America, now open in Jacksonville, Florida. , “We researched ... John Campbell. “Jacksonville’s lifestyle, waterways and beautiful beaches fit perfectly with the environment ...
Breaking Medicine News(10 mins):Health News:WEDI Announces Program for Annual Fall Conference: WEDI-Con 2015 2Health News:WEDI Announces Program for Annual Fall Conference: WEDI-Con 2015 3Health News:Mats Wilander, 7 Grand Slam Title Winner and Tennis Legend, Now Plays Without Joint Pain 2Health News:Mats Wilander, 7 Grand Slam Title Winner and Tennis Legend, Now Plays Without Joint Pain 3Health News:PartnerTech Supports Economic Growth as Host 2Health News:ERT to Demonstrate Innovation Lab Prototypes at European PRO / eCOA Congress 2Health News:ERT to Demonstrate Innovation Lab Prototypes at European PRO / eCOA Congress 3Health News:Global Digital Opens USA Digital Agency Hub 2
... awareness of maritime pollution and secure a place in history ... Pacific Ocean from San Francisco on Thursday. ... her lightweight 24-foot (seven meter) silver rowing boat and is ... trek across the vast expanse of the Pacific. ...
... Trump has confirmed that she is set to marry her ... ,However, the confirmation will come as a surprise to her ... ,The ex-wife of Donald Trump revealed her plans to become ... she writes a weekly advice column. ,The 58-year-old ...
... she often surfs porn websites, for she believes that it ... ,The estranged wife of rocker Marilyn Manson feels that ... ,"Amateur pornography is a great thing. You can find ... saying. ,She insists that she is just like ...
... involved in some of the highest-profile health scares involving ... product safety, a top official said Friday. ... fundamental problems behind issues relating to food product safety," ... top product safety agency told a news conference. ...
... 20 million pounds to his estranged wife Heather Mills in ... million pounds, if reports are to be believed. ... in the range of somewhere between 25 to 30 million ... ,However, their stubbornness is now indicating that they ...
... Indian Council of Medical Research Director-General N. K. Ganguly on ... trials conducted in India would be registered. These trials ... ,The national registry will make the trails more transparent. It ... researcher who plans to conduct drug trials on humans is ...
Cached Medicine News:Health News:Briton Set for Pacific Solo Odyssey to Highlight Warming 2Health News:China Vows to Improve Food Safety in Wake of Health Scares 2Health News:Clinical Trials Registry Launched in India 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: